Reminder: RDLA’s October Legislative Webinar/Conference Call TODAY

October 26, 2016

Wednesday, October 26th: 1:00 pm to 2:00 pm EST 
Click ‘register’ below to RSVP and receive the call in number and webinar info:



  1. Newborn Screening & the CDC: Cheryl Jaeger, Principal, Williams & Jensen
  2. 340B Drug Pricing Program: Michele Oshman, Director of Federal Advocacy and Alliance Development, Eli Lilly
  3. Lymphedema Treatment Act:Patricia Egan, Interim Executive Director & CEO, National Lymphedema Network
  4. Newborn Screening in California: Vignesh Ganapathy, Manager of Advocacy and Government Relations, EveryLife Foundation
  5. Capitol Hill Update: Max Bronstein, Senior Director of Advocacy and Science Policy, EveryLife Foundation


Agenda is OPEN, please submit possible agenda items to [email protected]

Once a month RDLA convenes in person and/or over the phone to discuss legislation and developments that affect the rare disease community. The meeting/conference calls are essentially a clearing house for legislation and participation does not imply support for any of the policy proposals or legislation that are discussed or promoted.

Stay Connected

Sign up for updates straight to your inbox.